- Lee S. Cohen, MD
- John A. Fromson, MD
- Dan V. Iosifescu, MD, MSc
At the end of this educational activity, participants should be able to:
- Identify the risks and benefits of treatment options for depression during pregnancy, and counsel patients accordingly.
- Recognize characteristics that may help clinicians identify bipolar disorder in patients presenting with depressive symptoms.
- Recognize the reciprocal and complex relationship between medical illness and depression.
Director, Center for Women's Mental Health Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital
Professor of Psychiatry, Harvard Medical School
Co-Chair, Reproductive Mental Health Initiative Office of Reproductive Health/Veterans Health Administration
Director of Professional Development, Massachusetts General Hospital Psychiatry Academy
Assistant Professor of Psychiatry, Harvard Medical School
Director, Mood and Anxiety Disorders Program, Mount Sinai Medical Center
Associate Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
No CME credit will be offered for this activity. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. This activity has expired. CME/CE Released: 3/17/2010; Valid for credit through 3/17/2013.
Even though this event is no longer accredited, providing information regarding planning, disclosure, and conflict of interest is important to us.This activity was accredited by McLean Hospital.
Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:
Robert J. Birnbaum, MD, PhD: Planner
John A. Fromson, MD: Planner, reviewer
Anan Nathif, EdM: Planner
Tristan Gorrindo, MD: Planner
Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
The following speaker and/or his spouse/partner have reported no relevant financial relationships with a commercial interest:
John A. Fromson, MD
The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:
Lee Cohen, MD
Astra-Zeneca Pharmaceuticals; Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; National Institute on Aging; National Institutes of Health; National Institute of Mental Health; Pfizer, Inc.
Eli Lilly & Company
Dan Iosifescu, MD, MMSc
Aspect Medical Systems, Forest Laboratories, Janssen Pharmaceuticals, NARSAD, NIH
Eli Lilly & Co.; Pfizer, Inc.; Forest Laboratories; Reed Medical Education